Delivery Order SPE2DB25D7067-SPE2DB25FSVQE
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,239.14 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This non-competitive, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and federal healthcare settings for immunization programs across the...
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $3,441.72 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine indicated for immunization against hepatitis B virus infection across various...
- The Defense Logistics Agency awarded a $19,926.00 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used across military medical treatment facilities and veteran healthcare systems to support immunization...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for ENGERIX-B 20 mcg/mL syringes valued at $1,382.45. This competitive, non-set-aside delivery order is scheduled for completion by July 21, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine product, reflecting the federal government's ongoing pharmaceutical supply requirements for military and defense healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $9,476.83 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on August 27, 2025, with completion scheduled for August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and federal healthcare settings...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,498.00 to supply ENGERIX-B 20 MCG/ML syringes, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. ENGERIX-B is a hepatitis B vaccine commonly used in military and veteran healthcare settings, aligning with the Department of...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes under a firm fixed price contract. This non-set-aside award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $29,956.70 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML syringes. This delivery order was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. ENGERIX-B is a hepatitis B...